Suvretta Capital Management as of Sept. 30, 2022
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 72 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Las Vegas Sands (LVS) | 5.1 | $123M | 3.3M | 37.52 | |
UnitedHealth (UNH) | 5.1 | $122M | 241k | 505.04 | |
Union Pacific Corporation (UNP) | 4.3 | $104M | 533k | 194.82 | |
Microsoft Corporation (MSFT) | 3.7 | $89M | 382k | 232.90 | |
Walt Disney Company (DIS) | 3.6 | $87M | 927k | 94.33 | |
Amazon (AMZN) | 3.4 | $83M | 734k | 113.00 | |
Otis Worldwide Corp (OTIS) | 3.4 | $83M | 1.3M | 63.80 | |
Lauder Estee Cos Cl A (EL) | 3.3 | $80M | 370k | 215.90 | |
Royalty Pharma Shs Class A (RPRX) | 3.1 | $74M | 1.8M | 40.18 | |
Global Payments (GPN) | 3.0 | $71M | 659k | 108.05 | |
Meta Platforms Cl A (META) | 2.8 | $68M | 498k | 135.68 | |
Hilton Worldwide Holdings (HLT) | 2.7 | $66M | 545k | 120.62 | |
Iqvia Holdings (IQV) | 2.7 | $65M | 358k | 181.14 | |
Tapestry (TPR) | 2.6 | $62M | 2.2M | 28.43 | |
Take-Two Interactive Software (TTWO) | 2.4 | $58M | 536k | 109.00 | |
Danaher Corporation (DHR) | 2.4 | $58M | 226k | 258.29 | |
Servicenow (NOW) | 2.4 | $58M | 154k | 377.61 | |
Thermo Fisher Scientific (TMO) | 2.4 | $58M | 115k | 507.19 | |
Kura Oncology (KURA) | 2.3 | $56M | 4.1M | 13.66 | |
Canadian Pacific Railway | 2.2 | $52M | 776k | 66.72 | |
Mastercard Incorporated Cl A (MA) | 2.1 | $52M | 182k | 284.34 | |
Metropcs Communications (TMUS) | 2.1 | $50M | 370k | 134.17 | |
Visa Com Cl A (V) | 2.0 | $48M | 272k | 177.65 | |
AmerisourceBergen (COR) | 1.9 | $46M | 342k | 135.33 | |
Horizon Therapeutics Pub L SHS | 1.8 | $44M | 713k | 61.89 | |
Arcellx Common Stock (ACLX) | 1.8 | $42M | 2.2M | 18.77 | |
Intra Cellular Therapies (ITCI) | 1.6 | $40M | 852k | 46.53 | |
Block Cl A (SQ) | 1.5 | $36M | 662k | 54.99 | |
McKesson Corporation (MCK) | 1.5 | $36M | 105k | 339.87 | |
Prokidney Corp Class A Ord Shs (PROK) | 1.2 | $29M | 3.2M | 9.01 | |
Fulcrum Therapeutics (FULC) | 1.2 | $29M | 3.5M | 8.09 | |
Kezar Life Sciences (KZR) | 1.2 | $28M | 3.3M | 8.61 | |
Sutro Biopharma (STRO) | 1.2 | $28M | 5.0M | 5.55 | |
Cogent Biosciences (COGT) | 1.2 | $28M | 1.9M | 14.92 | |
Chinook Therapeutics | 1.1 | $27M | 1.4M | 19.66 | |
Agios Pharmaceuticals (AGIO) | 1.1 | $27M | 959k | 28.28 | |
Insmed Com Par $.01 (INSM) | 1.1 | $27M | 1.2M | 21.54 | |
Eyepoint Pharmaceuticals Com New (EYPT) | 1.1 | $26M | 3.2M | 7.91 | |
Kalvista Pharmaceuticals (KALV) | 1.0 | $25M | 1.7M | 14.51 | |
Marinus Pharmaceuticals Com New (MRNS) | 1.0 | $24M | 3.5M | 6.65 | |
Prothena Corp SHS (PRTA) | 0.8 | $19M | 317k | 60.63 | |
Gfl Environmental Sub Vtg Shs (GFL) | 0.8 | $19M | 754k | 25.29 | |
Marriott Intl Cl A (MAR) | 0.8 | $19M | 135k | 140.14 | |
Point Biopharma Global | 0.7 | $18M | 2.3M | 7.73 | |
Heron Therapeutics (HRTX) | 0.5 | $12M | 2.8M | 4.22 | |
Eli Lilly & Co. (LLY) | 0.5 | $11M | 35k | 323.35 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.5 | $11M | 274k | 40.80 | |
Pepgen (PEPG) | 0.4 | $11M | 1.2M | 9.08 | |
Akili Common Stock (AKLI) | 0.3 | $8.2M | 3.6M | 2.26 | |
Alvotech Ordinary Shares (ALVO) | 0.3 | $6.8M | 1.0M | 6.76 | |
Ventyx Biosciences (VTYX) | 0.3 | $6.5M | 186k | 34.91 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.3 | $6.3M | 7.4M | 0.86 | |
Oric Pharmaceuticals (ORIC) | 0.3 | $6.1M | 1.9M | 3.20 | |
Pharvaris N V (PHVS) | 0.2 | $5.7M | 747k | 7.67 | |
Inflarx Nv (IFRX) | 0.2 | $5.7M | 2.1M | 2.64 | |
Solid Biosciences | 0.2 | $4.2M | 600k | 7.00 | |
Atai Life Sciences Nv SHS (ATAI) | 0.2 | $4.1M | 1.2M | 3.31 | |
Bolt Biotherapeutics (BOLT) | 0.2 | $4.0M | 2.7M | 1.48 | |
Gemini Therapeutics | 0.2 | $3.9M | 2.4M | 1.64 | |
Third Harmonic Bio (THRD) | 0.2 | $3.8M | 200k | 18.97 | |
Ultragenyx Pharmaceutical (RARE) | 0.2 | $3.7M | 89k | 41.41 | |
Molecular Partners Ads (MOLN) | 0.1 | $2.7M | 400k | 6.69 | |
Aeglea Biotherapeutics | 0.1 | $2.1M | 4.1M | 0.53 | |
Nuvalent Inc-a (NUVL) | 0.1 | $2.0M | 101k | 19.44 | |
Sio Gene Therapies | 0.1 | $1.7M | 5.9M | 0.28 | |
Ambrx Biopharma Sponsored Ads | 0.1 | $1.6M | 1.5M | 1.08 | |
Otonomy | 0.0 | $928k | 3.1M | 0.30 | |
Frazier Lifesciences Acqu Cl A Shs | 0.0 | $872k | 88k | 9.97 | |
Biohaven (BHVN) | 0.0 | $388k | 62k | 6.30 | |
Benitec Biopharma | 0.0 | $286k | 769k | 0.37 | |
Opy Acquisition Corp I *w Exp 09/22/202 | 0.0 | $8.0k | 73k | 0.11 | |
Turmeric Acquisition Corp *w Exp 10/08/202 | 0.0 | $997.447500 | 53k | 0.02 |